TY - JOUR
T1 - Diaphragm thickening fraction predicts noninvasive ventilation outcome
T2 - a preliminary physiological study
AU - Mercurio, Giovanna
AU - D’Arrigo, Sonia
AU - Moroni, Rossana
AU - Grieco, Domenico Luca
AU - Menga, Luca Salvatore
AU - Romano, Anna
AU - Annetta, Maria Giuseppina
AU - Bocci, Maria Grazia
AU - Eleuteri, Davide
AU - Bello, Giuseppe
AU - Montini, Luca
AU - Pennisi, Mariano Alberto
AU - Conti, Giorgio
AU - Antonelli, Massimo
N1 - Funding Information:
MA has received payments for Board participation from Maquet, Air Liquide and Chiesi. GC has received payments for lectures from Chiesi Pharmaceuticals SpA. DLG has received payments for travel expenses by Maquet, Getinge and Air Liquide. DLG and MA disclose a research grant by General Electric Healthcare.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Background: A correlation between unsuccessful noninvasive ventilation (NIV) and poor outcome has been suggested in de-novo Acute Respiratory Failure (ARF) patients. Consequently, it is of paramount importance to identify accurate predictors of NIV outcome. The aim of our preliminary study is to evaluate the Diaphragmatic Thickening Fraction (DTF) and the respiratory rate/DTF ratio as predictors of NIV outcome in de-novo ARF patients. Methods: Over 36 months, we studied patients admitted to the emergency department with a diagnosis of de-novo ARF and requiring NIV treatment. DTF and respiratory rate/DTF ratio were measured by 2 trained operators at baseline, at 1, 4, 12, 24, 48, 72 and 96 h of NIV treatment and/or until NIV discontinuation or intubation. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the ability of DTF and respiratory rate/DTF ratio to distinguish between patients who were successfully weaned and those who failed. Results: Eighteen patients were included. We found overall good repeatability of DTF assessment, with Intra-class Correlation Coefficient (ICC) of 0.82 (95% confidence interval 0.72–0.88). The cut-off values of DTF for prediction of NIV failure were < 36.3% and < 37.1% for the operator 1 and 2 (p < 0.0001), respectively. The cut-off value of respiratory rate/DTF ratio for prediction of NIV failure was > 0.6 for both operators (p < 0.0001). Conclusion: DTF and respiratory rate/DTF ratio may both represent valid, feasible and noninvasive tools to predict NIV outcome in patients with de-novo ARF. Trial registration ClinicalTrials.gov Identifier: NCT02976233, registered 26 November 2016.
AB - Background: A correlation between unsuccessful noninvasive ventilation (NIV) and poor outcome has been suggested in de-novo Acute Respiratory Failure (ARF) patients. Consequently, it is of paramount importance to identify accurate predictors of NIV outcome. The aim of our preliminary study is to evaluate the Diaphragmatic Thickening Fraction (DTF) and the respiratory rate/DTF ratio as predictors of NIV outcome in de-novo ARF patients. Methods: Over 36 months, we studied patients admitted to the emergency department with a diagnosis of de-novo ARF and requiring NIV treatment. DTF and respiratory rate/DTF ratio were measured by 2 trained operators at baseline, at 1, 4, 12, 24, 48, 72 and 96 h of NIV treatment and/or until NIV discontinuation or intubation. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the ability of DTF and respiratory rate/DTF ratio to distinguish between patients who were successfully weaned and those who failed. Results: Eighteen patients were included. We found overall good repeatability of DTF assessment, with Intra-class Correlation Coefficient (ICC) of 0.82 (95% confidence interval 0.72–0.88). The cut-off values of DTF for prediction of NIV failure were < 36.3% and < 37.1% for the operator 1 and 2 (p < 0.0001), respectively. The cut-off value of respiratory rate/DTF ratio for prediction of NIV failure was > 0.6 for both operators (p < 0.0001). Conclusion: DTF and respiratory rate/DTF ratio may both represent valid, feasible and noninvasive tools to predict NIV outcome in patients with de-novo ARF. Trial registration ClinicalTrials.gov Identifier: NCT02976233, registered 26 November 2016.
KW - Acute respiratory failure
KW - Diaphragm thickening fraction
KW - Noninvasive ventilation
KW - Rapid shallow breathing index
KW - Ultrasound
UR - http://www.scopus.com/inward/record.url?scp=85109354199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109354199&partnerID=8YFLogxK
U2 - 10.1186/s13054-021-03638-x
DO - 10.1186/s13054-021-03638-x
M3 - Article
C2 - 34174903
AN - SCOPUS:85109354199
VL - 25
JO - Critical Care
JF - Critical Care
SN - 1466-609X
IS - 1
M1 - 219
ER -